Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
about
PKN3 is required for malignant prostate cell growth downstream of activated PI 3-kinase.Expression and regulation of CD97 in colorectal carcinoma cell lines and tumor tissuesRole of retinoids in the prevention and treatment of colorectal cancerGastric Cancer: New Drugs - New StrategiesEffects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cellsActivation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase: involvement of insulin receptor substrate-related adapter proteins.Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer.Novel expression patterns of PI3K/Akt/mTOR signaling pathway components in colorectal cancer.Heregulin β-1 induces loss of cell-cell contact and enhances expression of MUC1 at the cell surface in HCC2998 and MKN45-1 cells.Envelope-induced cell transformation by ovine betaretroviruses.Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis.Radiation-induced VEGF-C expression and endothelial cell proliferation in lung cancer.Immunohistochemical analysis of RTKs expression identified HER3 as a prognostic indicator of gastric cancer.Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.Therapeutic targeting of the phosphatidylinositol 3-kinase signaling pathway: novel targeted therapies and advances in the treatment of colorectal cancer.Molecular targeted therapies in advanced gastric cancer: does tumor histology matter?Clinical management of advanced gastric cancer: the role of new molecular drugs.Signet-ring Cells in the Skin: A Case of Late-onset Cutaneous Metastasis of Gastric Carcinoma and a Brief Review of Histological ApproachA phosphatidylinositol 3-kinase docking site in the cytoplasmic tail of the Jaagsiekte sheep retrovirus transmembrane protein is essential for envelope-induced transformation of NIH 3T3 cells.Pathophysiological role of the activation of p38 mitogen-activated protein kinases in poorly differentiated gastric cancer.Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor.CDX2 does not suppress tumorigenicity in the human gastric cancer cell line MKN45.Redundancy of radioresistant signaling pathways originating from insulin-like growth factor I receptor.Evidence that 3'-phosphorylated polyphosphoinositides are generated at the nuclear surface: use of immunostaining technique with monoclonal antibodies specific for PI 3,4-P(2).Association between the TGFB1 -509C/T and TGFBR2 -875A/G polymorphisms and gastric cancer: a case-control studyA specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells.The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.Csk defines the ability of integrin-mediated cell adhesion and migration in human colon cancer cells: implication for a potential role in cancer metastasis.
P2860
Q24563328-374FB539-FA75-4901-AEBF-D7B4A0445BC4Q24685247-0FE817F9-F68E-4456-B2E4-BC679B0B2973Q26781463-73736FCC-35E6-4CA2-912E-C297D42803F8Q27028079-F0C74C59-33DA-4565-9303-EF62A7D2F8B2Q28210401-504709A6-F67A-4B0B-BBD2-45312A2BB818Q30891486-D5C51FDF-D1DC-406B-AB62-83C80EE41B53Q33800942-782A685A-ED24-4F2C-992F-01EF010541D2Q33955907-B6DD3829-33AA-4E28-B74D-5A1A4B22AACEQ33956668-105F7DEB-299D-4121-8870-D322800E23BCQ34117767-BC9FD992-FE44-4CB5-97D8-63381282E249Q34365754-117A2994-C982-4BAC-9B45-E566F0CD7356Q34452430-A536DCD0-9322-4D65-8675-C933BB18BBFFQ34558856-9FF2ED48-2A8E-44FF-AA88-9068FCC5FEAFQ35051995-6DC715D8-8D6D-48B2-AFF4-19DE6F94A46CQ37824622-F08F325D-F13F-4630-BE2F-61108DA2D3C1Q38042938-E5A63817-937C-41BD-9081-644A825ACAB6Q38074157-C35D5123-91E1-4DAB-9E0F-28F406B8E5A5Q38263841-ED270990-1120-4142-98F2-535991DEC1E8Q39191919-FCEA7C35-F809-4C6B-A57D-5E4D8473FB09Q39605089-776FC2BB-6C32-4458-A846-516C943CDE36Q40084707-3324A415-A3B9-4DE1-9975-D7925CC041FDQ40290597-CD88BE77-D40E-45BA-A796-B06AB28AFC5CQ40343216-CC1E4A7E-2938-4B06-AD11-5B8121F8B07FQ40682186-7551E06A-5F81-453C-B541-D357F3FB88FAQ40879573-66FA0035-B0F3-496C-9E0F-E7397C4379CCQ42259485-9FE39CE3-E2CC-49AB-87EF-898415FC0119Q42834760-DB31476A-ACDD-49AA-B45D-1B21B30EF2C5Q44566221-43151236-7E08-4377-9914-28731E16E5F1Q44719667-84C3EC7F-B684-49BF-89A2-CF33DDE89F62
P2860
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@ast
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@en
type
label
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@ast
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@en
prefLabel
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@ast
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@en
P2093
P2860
P356
P1476
Dedifferentiation of adenocarcinomas by activation of phosphatidylinositol 3-kinase.
@en
P2093
Kobayashi M
Yanagihara K
P2860
P304
P356
10.1073/PNAS.96.9.4874
P407
P577
1999-04-01T00:00:00Z